Stephen M. Sainati

1.9k total citations
18 papers, 1.2k citations indexed

About

Stephen M. Sainati is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Stephen M. Sainati has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Stephen M. Sainati's work include Sleep and related disorders (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Stephen M. Sainati is often cited by papers focused on Sleep and related disorders (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Stephen M. Sainati collaborates with scholars based in United States, Germany and South Korea. Stephen M. Sainati's co-authors include Stanley A. Lorens, David Seiden, Gary Zammit, Sherry Wang‐Weigand, Jeffrey Zhang, Thomas Roth, Jianyun Zhang, Meliha Erman, Phyllis C. Zee and Gordon R. Bernard and has published in prestigious journals such as Critical Care Medicine, Life Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Stephen M. Sainati

18 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stephen M. Sainati

Since Specialization

Citations

This map shows the geographic impact of Stephen M. Sainati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Sainati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Sainati more than expected).

Fields of papers citing papers by Stephen M. Sainati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Sainati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Sainati. The network helps show where Stephen M. Sainati may publish in the future.

Co-authorship network of co-authors of Stephen M. Sainati

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Sainati. A scholar is included among the top collaborators of Stephen M. Sainati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Sainati. Stephen M. Sainati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	(409) A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety and Efficacy of NYX-2925 in Subjects with Painful Diabetic Peripheral Neuropathy 2019 ·Journal of Pain ·Sarah Torri, Stephen M. Sainati, (unknown), (unknown), Nathaniel P. Katz, (unknown)	3
2	Taking personalized medicine seriously: Biomarker approaches in phase IIb/III studies in major depression and schizophrenia 2015 ·PubMed ·Harald Murck, Thomas Laughren, Femke Lamers, Rosalind W. Picard, Sebastian Walther, Donald Goff, Stephen M. Sainati	14
3	A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis* 2010 ·Critical Care Medicine ·Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Jean‐Louis Vincent, Derek C. Angus, Naoki Aikawa, Ignace Demeyer, Stephen M. Sainati, (unknown), Charlie Cao, Masayuki Ii, Hideyasu Matsuda, (unknown), Jon Cohen	392
4	Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia 2007 ·Journal of Clinical Sleep Medicine ·Gary Zammit, Milton K. Erman, Sherry Wang‐Weigand, Stephen M. Sainati, Jeffrey Zhang, Thomas Roth	134
5	Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia 2006 ·Sleep Medicine ·Thomas Roth, David Seiden, Stephen M. Sainati, Sherry Wang‐Weigand, Jeffrey Zhang, Phyllis C. Zee	187
6	PIII-38Long-term effects of ramelteon on endocrine function in patients with chronic insomnia in a double-blind, placebo-controlled phase III study 2006 ·Clinical Pharmacology & Therapeutics ·Gary S. Richardson, Sherry Wang‐Weigand, Stephen M. Sainati, Serkalem Demissie	7
7	An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia 2005 ·Sleep Medicine ·Meliha Erman, David Seiden, Gary Zammit, Stephen M. Sainati, Jianyun Zhang	190
8	A Pharmacokinetic, Pharmacodynamic and Safety Study of Celecoxib in Subjects with Probable Alzheimer's Disease 2004 ·Clinical Research and Regulatory Affairs ·Stanford S. Jhee, Edyta J. Frackiewicz, Dwain Tolbert, Stephen M. Sainati, Aziz Karim, (unknown), (unknown)	4
9	Valdecoxib, a COX‐2‐Specific Inhibitor, Does Not Affect Cardiac Repolarization 2003 ·The Journal of Clinical Pharmacology ·Nenad Sarapa, (unknown), (unknown), Steven R. Cox, Steven F. Francom, Na Jin, (unknown), Stephen M. Sainati, (unknown), Joseph C. Fleishaker	2
10	Coadministration of Short‐Term Zolpidem with Sertraline in Healthy Women 1999 ·The Journal of Clinical Pharmacology ·(unknown), Stephen M. Sainati, Barbara F. Roth‐Schechter	19
11	Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women. 1998 ·PubMed ·(unknown), Stephen M. Sainati, Barbara F. Roth‐Schechter, John Macintyre	19
12	Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens. 1997 ·PubMed ·Antoni A Piergies, Stephen M. Sainati, Barbara F. Roth‐Schechter	5
13	Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis 1995 ·Clinical Pharmacology & Therapeutics ·Rashmi H. Barbhaiya, Umesh Shukla, (unknown), (unknown), Douglas S. Greene, Stephen M. Sainati	19
14	Safety, Tolerability, and Effect of Food on the Pharmacokinetics of Iloperidone (HP 873), a Potential Atypical Antipsychotic 1995 ·The Journal of Clinical Pharmacology ·Stephen M. Sainati, John W. Hubbard, (unknown), Kenneth Grasing, Martin Brecher	35
15	Intra-raphe benzodiazepines enhance rat locomotor activity: Interactions with GABA 1983 ·Pharmacology Biochemistry and Behavior ·Stephen M. Sainati	38
16	Intra-raphe muscimol induced hyperactivity depends on ascending serotonin projections 1982 ·Pharmacology Biochemistry and Behavior ·Stephen M. Sainati, Stanley A. Lorens	65
17	Midbrain Benzodiazepine-GABA-Serotonin Interactions: Effects on Locomotor Activity in the Rat 1982 ·Loyola eCommons (Loyola University Chicago) ·Stephen M. Sainati	1
18	Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior 1978 ·Life Sciences ·Stanley A. Lorens, Stephen M. Sainati	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact